National and regional asthma programmes in Europe

O Selroos, M Kupczyk, P Kuna, P Łacwik… - European …, 2015 - Eur Respiratory Soc
This review presents seven national asthma programmes to support the European Asthma
Research and Innovation Partnership in developing strategies to reduce asthma mortality and …

[HTML][HTML] Comparison of a β2-Agonist, Terbutaline, with an Inhaled Corticosteroid, Budesonide, in Newly Detected Asthma

…, T Persson, K Reinikainen, O Selroos… - … England Journal of …, 1991 - Mass Medical Soc
Background. The presence of airway inflammation even in mild asthma points to the potential
value of antiinflammatory therapy. We compared the effect of an inhaled corticosteroid, …

[HTML][HTML] Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma

…, K Nikander, T Persson, O Selroos… - … England Journal of …, 1994 - Mass Medical Soc
Background In a previous study, we found that two years of treatment with an inhaled
corticosteroid, budesonide, was more effective than treatment with an inhaled β 2 -agonist, …

Effect of early vs late intervention with inhaled corticosteroids in asthma

O Selroos, A Pietinalho, AB Löfroos, H Riska - Chest, 1995 - Elsevier
One hundred five consecutive patients with mild or moderate asthma not earlier treated with
inhaled corticosteroids and with a need of an inhaled bronchodilator of three or more doses …

Do airway clearance mechanisms influence the local and systemic effects of inhaled corticosteroids?

S Edsbäcker, P Wollmer, O Selroos, L Borgström… - Pulmonary …, 2008 - Elsevier
The role of airway clearance in inhaled drug therapy is complex. Disease-induced
bronchoconstriction results in a central drug-deposition pattern where mucociliary clearance is most …

Early treatment of stage II sarcoidosis improves 5-year pulmonary function

…, P Tukiainen, T Haahtela, T Persson, O Selroos - Chest, 2002 - Elsevier
Study objective To evaluate the 5-year prognosis ofpatients with stage I and stage II newly
detected (< 3 months)pulmonary sarcoidosis treated immediately after diagnosis …

Delivery devices for inhaled asthma medication: clinical implications of differences in effectiveness

O Selroos, A Pietinalho, H Riska - Clinical Immunotherapeutics, 1996 - Springer
This review deals with results of comparative clinical studies where 2 or more delivery devices
have been used, the lung deposition of the drug has been measured or is known and the …

Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study

…, P Tukiainen, T Haahtela, T Persson, O Selroos… - Chest, 1999 - Elsevier
Study objective To evaluate the efficacy of oral prednisolone, followed by inhaled budesonide,
in patients with newly diagnosed (< 3 months) stage I and stage II pulmonary sarcoidosis. …

The Finnish experience to save asthma costs by improving care in 1987-2013

…, T Klaukka, M Linna, RL Leskelä, O Selroos… - Journal of Allergy and …, 2017 - Elsevier
The Finnish National Asthma Program 1994-2004 markedly improved asthma care in the
1990s. We evaluated the changes in costs during 26 years from 1987 to 2013. Direct and …

Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler.

O Selroos, M Halme - Thorax, 1991 - thorax.bmj.com
BACKGROUND: High doses of inhaled corticosteroids are absorbed systemically and may
cause long term side effects. As rinsing the mouth out after use and inhaling through a …